Silibinin enhanced the efficacy of albendazole in treating the muscular phase of experimental trichinellosis

Bibliographic Information
Authors: Fahmy M.-E.A.; Esmat M.; Badawi M.; Abdel Shafi I.R.
Journal: Tropical Animal Health and Production
Publisher: Springer Science and Business Media B.V.
Publication Date: 7 May 2025
Volume / Issue: Volume 57 / Issue 4
Article No.: 209
ISSN: 494747
DOI: 10.1007/s11250-025-04429-0
Scopus: View on Scopus
PubMed: 40332448
Document Type: Article
Access: All Open Access; Green Open Access; Hybrid Gold Open Access
Authors and Affiliations
Fahmy M.-E.A., Medical Parasitology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Esmat M., Department of Medical Parasitology, Faculty of Medicine, Misr University for Science and Technology, 6th October City, Giza, Egypt; Badawi M., Department of Pathology, National Research Centre, Giza, Egypt; Abdel Shafi I.R., Department of Medical Parasitology, Faculty of Medicine, Cairo University, Cairo, Egypt
Abstract
Trichinella spiralis is a parasitic nematode with a special life cycle. Both adults and larvae live in two different niches in the same host (intestinal and muscular). The parasite is known to manipulate the immune system of the host to be able to survive. One of the pathways the parasite modulates is the programmed death 1/ programmed death ligand 1 (PD1/PDL1), a pathway important to maintain the immune homeostasis during chronic infections and cancers. Albendazole (ABZ) shows anti-trichinellosis efficacy, especially against the intestinal phase of the infection. In an attempt to discover a drug that would enhance the efficacy of ABZ against the muscular phase, we used 40 CD1 Swiss-Albino male mice divided into 5 groups: normal, infected, infected ABZ-treated, infected Silymarin (SM)-treated, and the infected-treated with a combination group. After euthanasia, the number of diaphragmatic larvae was estimated in the infected and the infected-treated groups. In addition, the tongues and hearts of all mice were subjected to histopathological and immunohistochemical processing and evaluation. Monotherapy groups showed a significant reduction of both larval count and PD1 local expression compared to the infected-only group, however, neither ABZ nor SM alone could reduce the inflammation accompanying infection. The most significant improvements were recorded in the combined treatment group with a reduction rate of 69.95%, a significant reduction of inflammatory infiltrates (p < 0.05), and significant modulation of PDL1 local expression (p < 0.05). So, Silibinin (the major active ingredient of SM) showed anti-trichinellosis activity and enhanced the efficacy of ABZ against the muscular phase of the infection. © The Author(s) 2025.
Keywords
Albendazole; Combination; Mice; PD1; Silymarin; Trichinellosis; Animals; Anthelmintics; Drug Synergism; Drug Therapy, Combination; Larva; Male; Silybin; Trichinella spiralis; anthelmintic agent; silibinin; animal; combination drug therapy; drug effect; drug potentiation; drug therapy; mouse; parasitology; trichinosis
Citation Information
Scopus Citations: 1
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
